Earlier this month, Aetna entered into a definitive agreement to acquire Humana in a deal valued at $37 billion. Under the deal, Humana stockholders will receive $125 in cash and 0.8375 Aetna common shares for each Humana share.
However, Maureen Scott, the lead plaintiff in the lawsuit, claims the deal undervalues Humana and accuses Humana and its board of directors of breaching their fiduciary duty to shareholders by agreeing to the deal, according to the report.
Ms. Scott also claims the Aetna-Humana deal underestimates the antitrust hurdles ahead.
The case is pending in Delaware Chancery Court.
More articles on healthcare industry lawsuits:
7 latest healthcare industry lawsuits
Physician receives 45-year sentence for administering chemotherapy to healthy patients
Florida Hospital hit with two data breach lawsuits
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
